Efficacy of Traditional Chinese Medicine Treatment alone for Recurrent and Refractory Castration-Resistant Prostate Cancer: A Case Report and Literature Review

Introduction: Prostate Cancer (PCa) is a malignant tumor that occurs in the epithelial gland of prostate, and it ranks 6th in the incidence rate of malignant tumors among men in China, while the death rate ranks 2nd. The probability of distant metastasis can be as 30 high as 70%, with bone metastasis being the most common. Currently, the treatment of metastatic Prostate Cancer (mPCa) is mainly endocrine therapy, but hormone resistance occurs in almost all patients, which makes the disease recurring and the difficulty of treatment dramatically increased. This paper aims to provide a new therapeutic idea and a turnaround for the treatment of androgen-resistant recurrent refractory prostate cancer through the treatment of a case of recurrent refractory prostate cancer by simple traditional Chinese medicine.